Linked from

The 43 pages that link to Corticosteroid, each with the reason it gives.

• InflammationRelated: Corticosteroids can reduce inflammation by broadly limiting inflammatory signaling.

• CataractRelated: Prolonged corticosteroid use can contribute to posterior subcapsular cataracts.

• Graft-versus-host diseaseRelated: Systemic corticosteroids are a common first-line treatment for significant acute disease.

• Duchenne muscular dystrophyRelated: Prednisone and deflazacort can slow loss of muscle strength and mobility in Duchenne.

• EncephalitisRelated: Corticosteroids may be used for selected immune-mediated forms of encephalitis.

• Muscular dystrophyRelated: Corticosteroids can preserve strength and mobility for a time in Duchenne muscular dystrophy.

• Cytokine stormRelated: They can reduce harmful inflammation in several cytokine-storm settings.

• UveitisRelated: Topical, injected, or systemic corticosteroids are used to control many forms of uveitis.

• Brain tumorRelated: Corticosteroids can reduce tumor-associated brain edema and relieve pressure symptoms.

• Cytokine release syndromeRelated: Corticosteroids are used for severe CRS or symptoms that do not respond adequately to tocilizumab.

• NeurocysticercosisRelated: Reducing inflammation is often necessary when antiparasitic treatment damages cysts and intensifies symptoms.

• Optic neuritisRelated: High-dose corticosteroids can accelerate visual recovery in typical acute optic neuritis.

• Autoimmune hemolytic anemiaRelated: These medicines are commonly initial treatment for warm antibody disease.

• CysticercosisRelated: They can limit inflammation triggered when cysts die during treatment.

• SarcoidosisRelated: Systemic corticosteroids are commonly used when sarcoidosis threatens organ function or causes substantial symptoms.

• Acoustic traumaRelated: Clinicians may consider corticosteroids soon after acute acoustic injury, though evidence and protocols vary.

• Chronic inflammatory demyelinating polyneuropathyRelated: Corticosteroids are an established treatment option, though responses and suitability vary.

• Bell's palsyRelated: Early oral corticosteroid treatment improves the chance of facial nerve recovery.

• Castleman diseaseRelated: Corticosteroids may control inflammation, often as part of systemic treatment.

• Takayasu arteritisRelated: Glucocorticoids are commonly used to control active vascular inflammation.

• Blood–aqueous barrierRelated: Corticosteroids can reduce inflammatory disruption of the barrier in uveitis.

• Diamond–Blackfan anemiaRelated: Corticosteroids can improve red-cell production in some affected patients, though responses vary.

• Immune thrombocytopenic purpuraRelated: A short course is a common initial treatment when ITP requires therapy.

• Landau–Kleffner syndromeRelated: Corticosteroids are used in some treatment approaches to reduce epileptiform activity and support language recovery.

• ToxocariasisRelated: Clinicians may use corticosteroids to limit damaging inflammation in severe visceral or ocular disease.